Figure 2 | Scientific Reports

Figure 2

From: Sodium-glucose cotransporter-2 inhibitors improve clinical outcomes in patients with type 2 diabetes mellitus undergoing anthracycline-containing chemotherapy: an emulated target trial using nationwide cohort data in South Korea

Figure 2

Crude and adjusted hazard ratios for clinical outcomes in the propensity score-matched cohorts. AMI—acute myocardial infarction; CI—confidence interval; DM—diabetes mellitus; HF—heart failure; HR—hazard ratio; SGLT2i—sodium-glucose cotransporter-2 inhibitor.

Back to article page